Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P46
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -17.71% |
| Q3 2025 | 19.15% |
| Q2 2025 | 51.90% |
| Q1 2025 | 168.77% |
| Q4 2024 | -99.82% |
| Q3 2024 | -8154.70% |
| Q2 2024 | 99.29% |
| Q1 2024 | -20522.22% |
| Q4 2023 | 100.74% |
| Q3 2023 | -246.45% |
| Q2 2023 | 71.83% |
| Q1 2023 | -285.15% |
| Q4 2022 | -86.97% |
| Q3 2022 | 339.64% |
| Q2 2022 | 16.94% |
| Q1 2022 | 35.46% |
| Q4 2021 | -17.82% |
| Q3 2021 | 24.38% |
| Q2 2021 | 17.71% |
| Q1 2021 | 6.83% |
| Q4 2020 | -22.40% |
| Q3 2020 | -35.65% |
| Q2 2020 | -8.42% |
| Q1 2020 | 9.80% |
| Q4 2019 | -7.01% |
| Q3 2019 | 22.51% |
| Q2 2019 | 41.92% |
| Q1 2019 | -53.27% |
| Q4 2018 | -68.72% |
| Q3 2018 | -21.52% |
| Q2 2018 | -31.74% |
| Q1 2018 | 50.05% |
| Q4 2017 | -101.31% |
| Q3 2017 | -42.64% |
| Q2 2017 | -125.67% |
| Q1 2017 | 0.00% |